Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus (Q35954719)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus |
scientific article |
Statements
1 reference
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus (English)
1 reference
Douglas R Hough
1 reference
Falk Hiepe
1 reference
Cynthia Aranow
1 reference
William Stohl
1 reference
Kevin M Latinis
1 reference
Mathew Thomas
1 reference
Morton A Scheinberg
1 reference
Ann Clarke
1 reference
Frank R Wellborne
1 reference
Carlos Abud-Mendoza
1 reference
Lilia Pineda
1 reference
Thi-Sau Migone
1 reference
Z John Zhong
1 reference
William W Freimuth
1 reference
W Winn Chatham
1 reference
BLISS-52 Study Group
1 reference
BLISS-76 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference